Pediatric graves' disease: Outcome and treatment

Journal of Pediatric Endocrinology and Metabolism

Volumn 16, Issue 9, 2003, Pages 1249-1255

  Gruñeiro, Laura ^a,b   Chiesa, Ana ^a   Finkielstain, Gabriela ^a   Heinrich, Juan Jorge ^a  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^b NONE   (Argentina)

Author keywords

Antihyroid drugs; Graves' disease; Methimazole; Outcome; Propylthiouracil; Radioiodine; Thyroidectomy; Treatment

Indexed keywords

ANTIHISTAMINIC AGENT; ANTITHYROID AGENT; IODINE 131; PROPYLTHIOURACIL; THIAMAZOLE; THYROID HORMONE;

ADOLESCENT; ADULT; AGRANULOCYTOSIS; ANGIONEUROTIC EDEMA; ARTHRALGIA; ARTICLE; CHILD; CONTROLLED STUDY; DATA ANALYSIS; DRUG ERUPTION; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; KAPLAN MEIER METHOD; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; REMISSION; SKIN MANIFESTATION; SUBTOTAL THYROIDECTOMY; TOXIC HEPATITIS; TREATMENT OUTCOME; URTICARIA;

ADOLESCENT; ANTITHYROID AGENTS; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; DECISION MAKING; EXOPHTHALMOS; FEMALE; FOLLOW-UP STUDIES; GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES; ISOANTIBODIES; MALE; PUBERTY; RETROSPECTIVE STUDIES; THYROIDECTOMY; THYROTROPIN; THYROXINE; TIME FACTORS; TREATMENT OUTCOME; TRIIODOTHYRONINE;

EID: 0346252503     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. La Franchi S, Mandel SH. Graves' disease in the neonatal period and childhood. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text, 7th Ed. Philadelphia, PA: Lippincott-Raven Publishers, 1996; 1000-1008.
2. Zimmerman D, Lteif AN. Thyrotoxicosis in children. Endocrinol Metab Clin North Am 1998; 27: 109-126.
3. Dallas JS, Foley JR. Hyperthyroidism. In: Lifshitz F, ed. Pediatric Endocrinology. A Clinical Guide. New York: Marcel Decker Inc., 1996; 401-414.
4. Gartner LA, Poth M. Graves' disease in children and adolescents. Endocrinologist 1995; 5: 422-430.
5. Lippe B, Landaw E, Kaplan SA. Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years. J Clin Endocrinol Metab 1987; 64: 1241-1987.
6. Hamburger JL. Management of hyperthyroidism in children and adolescents. J Clin Endocrinol Metab 1985; 60: 1019-1024.
7. Cooper DS. Antithyroid drugs for the treatment of hyperthyroidism caused by Graves' disease. Endocrinol Metab Clin North Am 1998; 27: 225-243.
8. Rivkees SA, Sklar C, Freemark M. The management of Graves' disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 1998; 83: 3767-3776.
9. Franklyn JA. The management of hyperthyroidism. N Engl J Med 1994; 330: 1731-1739.
10. Bartalena L, Bogazzi F, Martino E. Adverse effects of thyroid hormone preparations and antithyroid drugs. Drug Safety 1996; 15: 53-63.
11. Rudberg C, Johansson H, Akerstrom G, Tuvemo T, Karlsson FA. Graves' disease in children and adolescents. Late results of surgical treatment. Eur J Endocrinol 1996; 134: 710-715.
12. 131) for hyperthyroidism. N Engl J Med 1975; 292: 167-171.
13. Clark JD, Gelfand MJ, Elgazzar AH. Iodine 131 therapy of hyperthyroidism in pediatric patients. J Nucl Med 1995; 36: 442-445.
14. Kraiem Z, Newfield RS. Graves' disease in childhood. J Pediatr Endocrinol Metab 2001; 14: 229-243.
15. Romaldini JH, Bromberg N, Werner RS, Tanaka LM, Rodrigues HF, Werner MC, Farah CS, Reis LC. Comparison of effects of high and low dosage regimes of antithyroid drugs in the management of Graves' disease. J Clin Endocrinol Metab 1983; 57: 563-570.
16. Rittmaster RS, Abbott EC, Douglas R, Givner ML, Lehmann L, Reddy S, Salisbury SR, Shlossberg AH, Tan MH, York SE. Effect of methimazole, with or without L-thyroxine, on remission rates in Graves' disease. J Clin Endocrinol Metab 1998; 83: 814-818.
17. Glaser NS, Styne DM. Predictors of early remission of hyperthyroidism in children. J Clin Endocrinol Metab 1997; 82: 1719-1726.
18. Lejarraga H, Orfila G. Estandares de peso y talla para. niños y niñas argentinos desde el nacimiento hasta la madurez [Weight and height standards for Argentinean girls and boys from birth to maturity]. Arch Arg Pediatr 1987; 85: 209-222.
19. Cole T, Freeman JV, Preece MA. Body mass index reference curves for the UK, 1990. Arch Dis Child 1995; 73: 25-29.
20. Ladeson PW. Diagnosis of thyrotoxicosis. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text, 6th Ed. Philadelphia, PA: Lippincott Co., 1991; 55: 880-886.
21. Lazar L, Kalter-Leibovici O, Pertzelan A, Weintrob N, Josefberg Z, Phillip M. Thyrotoxicosis in prepubertal children compared with pubertal patients. J Clin Endocrinol Metab 2000; 85: 3678-3682.
22. Barnes HV, Blizzard RM. Antithyroid drug therapy for toxic diffuse goiter (Graves' disease) - thirty years experience in children and adolescents. J Pediatr 1997; 91: 313-320.
23. Maenpaa J, Kuusi A. Childhood hyperthyroidism: results of treatment. Acta Paediatr Scand 1980; 69: 137-142.
24. Crawford JD. Hyperthyroidism in children. A reevaluation of treatment. Am J Dis Child 1981; 135: 109-110.
25. Buckingham BA, Costin G, Roe TF, Weitzman JJ, Rogut MD. Hyperthyroidism in children. A reevaluation of treatment. Am J Dis Child 1981; 135: 112-117.
26. Hayles AB, Zimmermann D. Graves' disease in childhood. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text, 5th Ed. Philadelphia, PA: Lippincott, 1996; 1414-1423.
27. Armheim JA, Kenny FM, Ross D. Granulocytopenia, lupus like syndrome and other complications of propylthiouracil therapy. J Pediatr 1970; 76: 54-73.
28. Collen RJ, Landaw EM, Kaplan SA, Lippe BM. Remission rates of children and adolescents with thyrotoxicosis treated with antithyroid drugs. Pediatrics 1980; 65: 550-556.
29. Schulman DJ, Muhar J, Jorgensen EV, Diamond FB, Bercu BB, Root AW. Autoinmune hyperthyroidism in prepubertal children and adolescents. Comparison of clinical and biochemical features at diagnosis and response to medical therapy. Thyroid 1997; 7: 755-760.